| Patrick A Raymond, MD | |
|
614 W Duarte Rd, Arcadia, CA 91007-7601 | |
| (626) 445-4714 | |
| Not Available |
| Full Name | Patrick A Raymond |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 41 Years |
| Location | 614 W Duarte Rd, Arcadia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497781363 | NPI | - | NPPES |
| 50084227 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | G52818 (California) | Primary |
| Entity Name | Patrick Raymond M D Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295769453 PECOS PAC ID: 0042371213 Enrollment ID: O20081205000484 |
News Archive
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
A study presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting shows of 105 patients in the Atlanta metro area, only 18 percent of the women who saw a private practice gynecologist were told about uterine fibroid embolization (UFE), a minimally invasive treatment for uterine fibroids provided by interventional radiologists.
A study led by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Colorectal cancer is the cancer of the large intestine (colon and rectum) and is the most common cancer in Singapore.
As efforts to implement the health law move forward, Politico Pro talks to Michael Leavitt about state exchanges, and KHN examines the administration's strategy for prevention funding.
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick A Raymond, MD Po Box 3098, Torrance, CA 90510-3098 Ph: (310) 792-3914 | Patrick A Raymond, MD 614 W Duarte Rd, Arcadia, CA 91007-7601 Ph: (626) 445-4714 |
News Archive
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
A study presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting shows of 105 patients in the Atlanta metro area, only 18 percent of the women who saw a private practice gynecologist were told about uterine fibroid embolization (UFE), a minimally invasive treatment for uterine fibroids provided by interventional radiologists.
A study led by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Colorectal cancer is the cancer of the large intestine (colon and rectum) and is the most common cancer in Singapore.
As efforts to implement the health law move forward, Politico Pro talks to Michael Leavitt about state exchanges, and KHN examines the administration's strategy for prevention funding.
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
› Verified 2 days ago
Casper Hu, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8000 | |
Dr. Rahtna Banerjee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-574-3540 | |
Jeffrey Rusheen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 614 W Duarte Rd, Arcadia, CA 91007 Phone: 626-445-4714 | |
Sandra Siokhyan Chiong, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 614 W Duarte Rd, Arcadia, CA 91007 Phone: 626-445-4714 Fax: 626-445-1701 | |
Susan Chiong Choa, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-445-4441 Fax: 626-821-6955 | |
John Christopher Holloway, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 614 W Duarte Rd, Arcadia, CA 91007 Phone: 626-445-4714 | |
Sungkey Lee Chong, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-445-4441 Fax: 626-821-6955 |